Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2010-01-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Pharmaceutical Care in Diabetics Patients
NCT01580904
Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial
NCT00277732
Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus
NCT03196336
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
NCT05408936
Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes
NCT02526810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PHARMACEUTICAL CARE
PHARMACEUTICAL CARE
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
HEALTH USUAL CARE
HEALTH USUAL CARE
Usual care as defined in health consultations with doctors, nutritionists and nurses, access to laboratory tests and essential medicines
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PHARMACEUTICAL CARE
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
HEALTH USUAL CARE
Usual care as defined in health consultations with doctors, nutritionists and nurses, access to laboratory tests and essential medicines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* USE OF DIABETES ORAL MEDICATION
* MINIMAL GLYCOHEMOGLOBIN 7%
Exclusion Criteria
* PEOPLE UNABLE TO ATTEND THE STUDY SITE
* PARTICIPANTS OF OTHER PROGRAMS OF PHARMACEUTICAL CARE
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Ouro Preto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UNIVERSIDADE FEDERAL DE OURO PRETO
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LISIANE S EV, DR
Role: STUDY_CHAIR
Universidade Federal de Ouro Preto
ANDREA G GRABE, DR
Role: STUDY_DIRECTOR
Universidade Federal de Ouro Preto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de Ouro Preto
Ouro Preto, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0040.0.238.000-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.